Collaborate With Us
Let's build the next generation of autoimmune biomarkers.
We are seeking collaborators with lupus cohorts, longitudinal samples, therapeutic programs, and immune / multi-omics datasets.
Who We Work With
A platform built through collaboration.
MetaboType is advanced through partners across the autoimmune ecosystem.
Pharma
Therapeutic development and clinical-trial biomarkers.
Academic investigators
Cohort studies and longitudinal sample programs.
Clinical networks
Lupus and lupus nephritis patient populations.
Foundations
Disease-area strategy and patient impact.
Patient organizations
Community-informed research priorities.
What We're Seeking
Samples, cohorts and data that unlock longitudinal biology.
The platform's value grows with the breadth of longitudinal data connected to clinical outcomes.
Lupus patient cohortsLongitudinal clinical samplesTherapeutic development programsLupus nephritis studiesClinical trial networksBiobanksImmune & multi-omics datasets
What partners receive
- Access to longitudinal metabolomic analysis
- Candidate biomarker data
- Collaborative study design
- Integrated analysis with clinical outcomes
- Co-development opportunities
What makes a strong collaboration
- Well-characterized patient cohort
- Longitudinal samples
- Paired clinical outcomes
- Therapeutic intervention
- Disease-activity data
- Kidney / nephritis data where relevant
Start a Conversation
Tell us about your program.
Share your cohort, samples or therapeutic program. We'll respond to discuss how MetaboType can support your goals.
How we collaborate
- • Exploratory metabolomic analysis
- • Longitudinal biomarker development
- • Clinical-trial endpoint support
- • Shared data and publication